| | 1 | | |
| | 1.1 | | | |
| | 1.1.1 | | | | | | Articulado * | (Os valores indicados não incluem o IVA)
 | |
|
| | | | | | 0,000000 |
| EUR |
|
|
| | | | | | 1 | AQUISIÇÃO DE REAGENTES MONOCLONAIS DE IMUNOFENOTIPAGEM P/CITOMETRIA DE FLUXO - EUROFLOW DURANTE 2024 |
|
|
| | | | | | 1 |
| CD3 APC | 300,000000 | TESTE |
|
| |
|
|
| | | | | | 2 |
| CD4 PERCP CY 5.5 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 3 |
| CD4 APC | 200,000000 | TESTE |
|
| |
|
|
| | | | | | 4 |
| CD7 FITC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 5 |
| CD8 FITC | 200,000000 | TESTE |
|
| |
|
|
| | | | | | 6 |
| CD8 PE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 7 |
| CD8 APC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 8 |
| CD10 APC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 9 |
| CD11C APC | 200,000000 | TESTE |
|
| |
|
|
| | | | | | 11 |
| CD14 APC | 200,000000 | TESTE |
|
| |
|
|
| | | | | | 13 |
| CD25 PE | 50,000000 | TESTE |
|
| |
|
|
| | | | | | 14 |
| CD33 PE | 200,000000 | TESTE |
|
| |
|
|
| | | | | | 15 |
| CD33 APC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 17 |
| CD38 FITC | 400,000000 | TESTE |
|
| |
|
|
| | | | | | 18 |
| CD45 APC | 300,000000 | TESTE |
|
| |
|
|
| | | | | | 19 |
| CD45RA FITC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 20 |
| CD56 PE | 1 300,000000 | TESTE |
|
| |
|
|
| | | | | | 21 |
| CD57 FITC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 23 |
| CD64 PE | 50,000000 | TESTE |
|
| |
|
|
| | | | | | 25 |
| CD117 APC | 200,000000 | TESTE |
|
| |
|
|
| | | | | | 26 |
| CD138 V500-C | 500,000000 | TESTE |
|
| |
|
|
| | | | | | 27 |
| HLA B-27 | 350,000000 | TESTE |
|
| |
|
|
| | | | | | 30 |
| CD2 PACIFIC BLUE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 32 |
| CD3 APC-H7 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 33 |
| CD3 PERCP-CY5.5 | 150,000000 | TESTE |
|
| |
|
|
| | | | | | 34 |
| CD4 PACIFIC BLUE | 400,000000 | TESTE |
|
| |
|
|
| | | | | | 35 |
| CD4 APC-H7 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 36 |
| CD5 PERCP-CY5.5 | 400,000000 | TESTE |
|
| |
|
|
| | | | | | 37 |
| CD7 APC | 300,000000 | TESTE |
|
| |
|
|
| | | | | | 38 |
| CD8 APC-H7 | 300,000000 | TESTE |
|
| |
|
|
| | | | | | 39 |
| CD9 APC-H7 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 43 |
| CD11C PERCP-CY5.5 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 44 |
| CD14 APC-H7 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 45 |
| CD19 APC-H7 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 46 |
| CD20 PACIFIC BLUE | 800,000000 | TESTE |
|
| |
|
|
| | | | | | 47 |
| CD22 APC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 48 |
| CD22 PERCP-CY5.5 | 50,000000 | TESTE |
|
| |
|
|
| | | | | | 49 |
| CD26 PE | 50,000000 | TESTE |
|
| |
|
|
| | | | | | 51 |
| CD27 PERCP-CY5.5 | 50,000000 | TESTE |
|
| |
|
|
| | | | | | 52 |
| CD28 APC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 53 |
| CD30 PE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 54 |
| CD31 FITC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 55 |
| CD34 PERCP-CY5.5 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 57 |
| CD38 APC-H7 | 400,000000 | TESTE |
|
| |
|
|
| | | | | | 58 |
| CD39 PE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 61 |
| CD45RO PE-CY7 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 62 |
| CD81 APC-H7 | 400,000000 | TESTE |
|
| |
|
|
| | | | | | 66 |
| CD279 PE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 67 |
| IGM APC | 300,000000 | TESTE |
|
| |
|
|
| | | | | | 68 |
| HLA-DR PE-CY7 | 200,000000 | TESTE |
|
| |
|
|
| | | | | | 70 |
| HLA-DR PACIFIC BLUE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 71 |
| PERFORIN FITC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 73 |
| CD305 PE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 76 |
| CD45 V500-C | 1 100,000000 | TESTE |
|
| |
|
|
| | | | | | 77 |
| CD105 PE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 78 |
| CD123 APC | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 80 |
| GRANZYME PE | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 81 |
| CD16 PE-CY7 | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 82 |
| CD20+CD4-PB/CD45-OC515/CD8+LAMBDA-FITC/CD56+KAPPA-PE/CD5-PERCP-CY5.5/CD19+TCR GD | 1 000,000000 | TESTE |
|
| |
|
|
| | | | | | 83 |
| MM MRD PANEL ( PAINEL DOENCA RESIDUAL MINIMA - MIELOMA MULTIPLO) | 20,000000 | TESTE |
|
| |
|
|
| | | | | | 84 |
| BCP-ALL-T1 TUBO LIOFILIZADO (CD10; CD19; CD20; CD34; CD38; CD45; CD58; CD66C) | 10,000000 | TESTE |
|
| |
|
|
| | | | | | 85 |
| B-CLPD TUBO LIOFILIZADO (CD10; CD19; CD20; CD23; CD43; CD45; CD79; CD200) | 200,000000 | TESTE |
|
| |
|
|
| | | | | | 86 |
| ALOT TUBO LIOFILIZADO (CYCD3; CD45; CYMPO; CYCD79A; CD34; CD19; CD7; SMCD3) | 60,000000 | TESTE |
|
| |
|
|
| | | | | | 87 |
| AML_MDS1 TUBO LIOFILIZADO (HLA-DR; CD45; CD16; CD13; CD34; CD11B; CD117; CD10) | 210,000000 | TESTE |
|
| |
|
|
| | | | | | 88 |
| AML_MDS2 TUBO LIOFILIZADO (HLA-DR; CD45; CD35; CD64; CD34; CD300E; CD117; CD14) | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 89 |
| AML_MDS3 TUBO LIOFILIZADO (HLA-DR; CD45; CD36; CD105; CD34; CD33; CD117; CD71) | 50,000000 | TESTE |
|
| |
|
|
| | | | | | 90 |
| AML_MDS4 TUBO LIOFILIZADO (HLA-DR; CD45; TDT; CD56; CD34; CD7; CD117; CD19) | 40,000000 | TESTE |
|
| |
|
|
| | | | | | 91 |
| TRBC1 FITC | 300,000000 | TESTE |
|
| |
|
|
| | | | | | 92 |
| CD41A FITC | 50,000000 | TESTE |
|
| |
|
|
| | | | | | 93 |
| SOLUCAO LISE DE GLOBULOS VERMELHOS | 1,000000 | LITRO |
|
| |
|
|
| | | | | | 94 |
| SOLUCAO DESINFECTANTE | 15,000000 | LITRO |
|
| |
|
|
| | | | | | 95 |
| SOLUCAO PERMEABILIZANTE | 25,000000 | FRASCO |
|
| |
|
|
| | | | | | 96 |
| SOLUCAO TAMPAO | 780,000000 | LITRO |
|
| |
|
|
| | | | | | 97 |
| SOLUCAO TAMPAO DE LAVAGEM | 30,000000 | LITRO |
|
| |
|
|
| | | | | | 98 |
| ESTABILIZADOR ANTIGENIO CELULAR | 40,000000 | ML |
|
| |
|
|
| | | | | | 99 |
| ESFERAS PARA CONTAGENS ABSOLUTOS | 100,000000 | TESTE |
|
| |
|
|
| | | | | | 100 |
| SOLUCAO LISE P/IDENTIFICACAO DE CELULAS NEOPLASICAS RESIDUAIS | 100,000000 | ML |
|
| |
|
|